TLR4 and prostate carcinoma: However, the results from a meta-analysis suggest that the TLR4 Asp299Gly polymorphism had a protective effect in prostate cancer; whereas, both TLR4 Asp299Gly and Thr399Ile polymorphisms were associated with an elevated gastrointestinal cancer risk [36–37].